News of Note—NovaVax, GeoVax and more

Here's some other vaccine news of note for this week.

> Looking to take on Sanofi's Fluzone HD, NovaVax is kicking off a phase 1/2 study of its NanoFlu candidate in older adults. Release

> GeoVax reported that its Zika vaccine candidate protected 100% of mice in a lethal challenge. Release

> CEL-SCI won a $1.5 million grant from the National Institutes of Health to work on a rheumatoid arthritis vaccine candidate. Release

> A team at Oregon State University isolated two proteins as promising candidates for a gonorrhea vaccine. Release